Researchers found that agile 3+ and agile 4 scores from vibration-controlled transient elastography had the highest discriminatory power in predicting liver-related events in patients with metabolic dysfunction-associated steatotic liver disease. These scores accurately categorized patients between high and low risk categories, with a decrease in agile 3+ score by more than 20% linked to a substantial reduction in event risk. This suggests that single or serial agile scores could serve as alternatives to liver biopsy in clinical practice and clinical trials for steatohepatitis.
Journal Article by Lin H, Lee HW (…) Wong VW et 36 al. in JAMA